428 related articles for article (PubMed ID: 12503271)
1. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
Vasil'ev IuV; Li IA
Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
[TBL] [Abstract][Full Text] [Related]
3. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Dutch Esophagitis Study Group.
Wesdorp IC; Dekker W; Festen HP
Clin Ther; 1997; 19(5):1048-57. PubMed ID: 9385492
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous treatment with quamatel in reflux-esophagus and erosive gastritis].
Ivanova S; Gavrilova V; Dimitrov L
Vutr Boles; 2000; 32(4):48-51. PubMed ID: 11688330
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
[TBL] [Abstract][Full Text] [Related]
7. Famotidine 40mg B.I.D. in the treatment of reflux oesophagitis.
Ahmed W; Qureshi H; Alam SE; Zuberi SJ
J Pak Med Assoc; 1995 Sep; 45(9):241-3. PubMed ID: 8683830
[TBL] [Abstract][Full Text] [Related]
8. Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.
Simon TJ; Roberts WG; Berlin RG; Hayden LJ; Berman RS; Reagan JE
Clin Ther; 1995; 17(6):1147-56. PubMed ID: 8750406
[TBL] [Abstract][Full Text] [Related]
9. Famotidine in gastroesophageal reflux disease (GERD).
Wesdorp IC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
[TBL] [Abstract][Full Text] [Related]
10. Medical treatment of gastroesophageal reflux disease: options and priorities.
Thomson AB
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
[TBL] [Abstract][Full Text] [Related]
11. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
12. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y
Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of gastroesophageal reflux in adults].
Cadiot G
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):100-2. PubMed ID: 8737506
[No Abstract] [Full Text] [Related]
15. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
[No Abstract] [Full Text] [Related]
16. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
Mainguet P
Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
[No Abstract] [Full Text] [Related]
17. [Clinical aspects of Kvamatel (famotidine) administration].
Golochevskaia VS
Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
[No Abstract] [Full Text] [Related]
18. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
Kusunoki H; Kusaka M; Kido S; Yamauchi R; Fujimura Y; Watanabe Y; Kobori M; Miwa H; Tomita T; Kin Y; Hori K; Tano N; Sugimoto K; Nakamura Y; Fujimoto K; Oza N; Matsunobu A; Ono N; Fuyuno S; Kinoshita Y; Adachi K; Yuki M; Fujisawa T; Haruma K
J Gastroenterol; 2009; 44(4):261-70. PubMed ID: 19280112
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of mild to moderate reflux esophagitis with the H2-blocker famotidine].
Kratochvil P; Brandstätter G; Janisch P
Wien Med Wochenschr; 1992; 142(18):418-22. PubMed ID: 1475988
[TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
